Simon Pimstone is a founder, Director, and President & Chief Executive Officer at Xenon Pharmaceuticals Inc. Dr. Pimstone received his MD from the University of Cape Town. He is an internal medicine specialist (FRCPC) with an interest in cardiovascular disease. Prior to his specialization, he trained as a clinical research fellow with the Department of Medical Genetics at the University of British Columbia and obtained his PhD through the University of Amsterdam in cardiovascular genetics.

Dr. Pimstone has served as a consultant physician at the St. Paul’s Hospital Lipid Clinic in Vancouver, as a Director of the Providence Healthcare Research Trust, a Director of the AllerGEN National Centre of Excellence, an Advisory Member of the SFU Biotech MBA program, and he is a Director of BIOTECanada. Dr. Pimstone is a member of the Young Presidents’ Organization. In 2005, he received the Business in Vancouver Top 40 under 40 Award and the Globe & Mail’s Canadian Top 40 Under 40 Award in 2004. Dr. Pimstone is the author of numerous peer-reviewed publications and is also a regular guest speaker at international scientific meetings and healthcare conferences.